Efficacy and safety of ultrasound-guided high-intensity focused ultrasound for uterine adenomyosis: Preliminary experience from a case series

In: World Journal of Advanced Research and Reviews · 2022 · vol. 13(2) , pp. 359–366 · doi:10.30574/wjarr.2022.13.2.0158 · W4212995753
article OA: hybrid CC0 ⤵ 1 in-corpus citation
📄 Open PDF View on OpenAlex View at publisher

Abstract

Objective: This prospective cohort study was to evaluate the efficacy and safety of ultrasound-guided High-Intensity Focused Ultrasound (HIFU) in the treatment of uterine adenomyosis. Methods: Ten premenopausal women with symptomatic adenomyosis underwent ultrasound-guided HIFU therapy. Their symptoms were compared using symptom severity scores before and at 3, 6 and 12 months after treatment. The sizes of their uteri and adenomyotic lesions at 6 months after treatment were compared with those of pre-treatment as determined by magnetic resonance imaging. Results: The menstrual pain scores were reduced by 45.5% (-83.3–100%) at 3-month, 57.3% (-83.3–100%) at 6-month and 27.9% (-100–100%) at 12-month after treatment. The modified Uterine Fibroid Symptom and Quality of Life scores were reduced by 50.0% (9.1–69.7%) at 3-month, 40.9% (27.3–66.7%) at 6-month and 39.5% (0–70.0%) at 12-month after treatment. The uterus and adenomyosis volumes were reduced by 24.4% (1.2–42.0%) and 46.3% (2.1-78.4%) at 6-month after treatment, respectively. Two patients (20%) had significant treatment-related complications and three patients (30%) required subsequent surgical interventions. Conclusions: Although ultrasound-guided HIFU appears to provide symptomatic relief to most patients with adenomyosis, its long-term effectiveness and safety require further evaluation in a larger cohort of patients, and may improve with clinical experience.

My notes (saved in your browser only)

Condition tags

adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (19)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK